Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation / 대한뇌졸중학회지
Journal of Stroke
; : 259-275, 2019.
Article
em En
| WPRIM
| ID: wpr-766264
Biblioteca responsável:
WPRO
ABSTRACT
Non-Vitamin K antagonist oral anticoagulants (NOACs) have been extensively investigated in medical conditions at high risk of venous or arterial thrombosis other than atrial fibrillation (AF), including hip or knee arthroplasty, acute venous thromboembolism (VTE), cancer-associated VTE, acute coronary syndrome (ACS), stable atherosclerotic vascular disease, chronic heart failure, and embolic stroke of undetermined source (ESUS). Two large ESUS trials failed to show the benefit of rivaroxaban or dabigatran, and large randomized controlled trial (RCT) data of NOACs are lacking for another potential candidates of patent foramen ovale-related stroke, acute ischemic stroke, and cerebral venous thrombosis. On the other hand, high quality evidences of NOACs have been compiled for VTE prophylaxis after hip or knee arthroplasty, acute VTE, cancer-associated VTE, and concomitant ACS and AF, which have been reflected in clinical practice guidelines. In addition, RCTs showed the benefit of very low dose rivaroxaban in combination with antiplatelet therapy in patients with ACS and in those with stable cardiovascular disease. This article summarizes the accumulated evidences of NOACs in cardiovascular diseases beyond AF, and aims to inform healthcare providers of optimal regimens tailored to individual medical conditions and help investigators design future clinical trials.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Pesquisadores
/
Fibrilação Atrial
/
Tromboembolia
/
Trombose
/
Doenças Vasculares
/
Doenças Cardiovasculares
/
Pessoal de Saúde
/
Artroplastia do Joelho
/
Trombose Venosa
/
Acidente Vascular Cerebral
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Guideline
Limite:
Humans
Idioma:
En
Revista:
Journal of Stroke
Ano de publicação:
2019
Tipo de documento:
Article